Brief: Embecta Q1 Revenue USD 261.9 Million
06/02/2025 11:30
Feb 06 (Reuters) - Embecta Q1 dividend USD 0.15. * Q1 operating income USD 28.7 million * Q1 adjusted gross profit USD 164.2 million * Q1 adjusted operating income USD 80.5 million * Q1 gross profit USD 157.1 million * Q1 adjusted EBITDA USD 97.3 million
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel